Islet transplantation: the quest for an ideal source

Area of Science:

• Endocrinology and Metabolic Diseases
• Transplantation Immunology
• Regenerative Medicine

Background:

• Diabetes mellitus treatment relies on effective islet cell replacement.
• Islet transplantation offers a potential cure but faces challenges in cell supply and immune rejection.
• Progress is marked by distinct research eras focusing on isolation, efficacy, and clinical protocols.

Observation:

• Early research established islet transplantation's potential to reverse diabetes in various models.
• The Edmonton protocol standardized procedures and introduced improved immunosuppression for human islet allotransplantation.
• A critical need exists for alternative islet sources, including xenografts and stem cells, to address shortages.

Findings:

• Efficient immunoisolation techniques are crucial for the large-scale clinical application of islet transplantation.
• Review covers historical advances, current human allotransplantation, and various immunoisolation strategies.
• Novel approaches focus on enhancing vascularity and islet cell function at the transplantation site.

Implications:

• Future immunoisolation technologies hold promise for enhancing human islet allotransplantation.
• Overcoming cell supply limitations and immune barriers is essential for widespread diabetes therapy.
• Continued innovation in islet sourcing and transplantation techniques can significantly improve patient outcomes.